Ipca Laboratories Ltd

Ipca Laboratories Ltd is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra. It produces theobromine, acetylthiophene, and p-bromotoluene as active pharmaceutical ingredients (APIs). Ipca sells these APIs and their intermediates globally. It produces more than 150 formulations that include oral liquids, tablets, dry powders, and capsules.

Ipca Laboratories was founded in 1949 by a group of businessmen and medical professionals. The company’s name is an acronym for the Indian Pharmaceutical Combine Association. Ipca Laboratories went public in 1980 and is listed on the Bombay Stock Exchange and the National Stock Exchange of India.

Ipca Laboratories has a strong research and development (R&D) division that is constantly working to develop new APIs and formulations. The company has a number of manufacturing facilities located in India, the United States, and Europe. Ipca Laboratories exports its products to over 120 countries.
With a global presence in over 120 countries, Ipca reaches patients and healthcare professionals around the world. The company’s commitment to compliance and regulatory standards has resulted in various certifications, including WHO-GMP, USFDA, UKMHRA, and more.

Ipca Laboratories is a well-known and respected pharmaceutical company in India. It has won several awards for its quality products and its commitment to corporate social responsibility. The company is also a member of the World Health Organization’s (WHO) Prequalification Programme.

Here are some of the key facts about Ipca Laboratories Limited:

  • Founded in 1949
    Headquarters in Mumbai, Maharashtra, India
    Manufactures APIs and formulations
    Exports products to over 120 countries
    Member of the WHO’s Prequalification Programme
    Won several awards for its quality products and corporate social responsibility

Showing all 2 results